JHS Svendgaard Laboratories Ltd Share Price Today - JHS Svendgaard Laboratories Ltd Stock Price Live NSE/BSE

JHS Svendgaard Laboratories Ltd

NSE: JHS BSE: 532771

₹8.85

(-1.67%)

Sat, 09 May 2026, 03:09 am

MTF 5xInvest in JHS Svendgaard Laboratories Ltd with 5x Leverage Buy with MTF

Market Cap786.7M

PE Ratio0

Dividend0

Consumer Non-Durables

Household/Personal Care

24.5K

JHS Svendgaard Laboratories Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
76.57
Net Profit
-19.74
P/B
0.56
Sector P/E
49.37
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.37
Interest Cover (Industry)
5.48
ROCE (Industry)
9.55
RONW (Industry)
7.84
ROE
0
ROCE
0
Debt/Equity
0.03
EPS (TTM)
0
Dividend Yield
0
Book Value
20.44
Interest Cover
-16.10

Analysis

all

Pros

JHS Svendgaard Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Debt is covered by short term assets, assets are 17.5x debt.
JHS Svendgaard Laboratories's cash and other short term assets cover its long term commitments.
The level of debt compared to net worth has been reduced over the past 5 years (124.4% vs 3.2% today).
JHS Svendgaard Laboratories's level of debt (3.2%) compared to net worth is satisfactory (less than 40%).

Cons

Unable to calculate sustainability of dividends as JHS Svendgaard Laboratories has not reported any payouts.
Unable to evaluate JHS Svendgaard Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate JHS Svendgaard Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
Operating cash flow is negative therefore debt is not well covered.
High level of physical assets or inventory.

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	33.85	34.56	34.56	34.56	34.56
FII	3.60	1.57	1.57	1.59	1.60
DII	0	0	0	0	0
Public	62.56	63.87	63.87	63.85	63.84
Government	0	0	0	0	0

Technical Analysis

RSI

52.06

MACD

0.09

50 DMA

8.70

200 DMA

10.58

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	14.45	11.46	10.15	8.47	7.16	5.48	2.49
Fibonacci	11.46	10.31	9.61	8.47	7.32	6.62	5.48
Camarilla	9.67	9.40	9.12	8.47	8.58	8.30	8.03

Pivots Level: Classic

+5.98

14.45

+2.99

11.46

+1.69

10.15

8.47

Pivot Point

LTP: 8.96

-1.30

7.16

-2.99

5.48

-5.98

2.49

Moving Average

SMAEMA

Period

Value

10-EMA
8.97
20-EMA
8.89
30-EMA
8.86
50-EMA
8.98
100-EMA
9.52
200-EMA
10.86

Announcement Date	Purpose	Action
10 Feb 2026	board-meetings	Quarterly Results
14 Nov 2025	board-meetings	Quarterly Results
28 Aug 2025	agm
19 Aug 2024	agm
04 Jun 2024	egm
06 Sept 2023	agm
11 Oct 2022	egm
10 Aug 2022	agm
03 Mar 2022	egm
06 Sept 2021	agm

JHS Svendgaard Laboratories Ltd

Varun Beverages Ltd

Hindustan Unilever Ltd

Britannia Industries Ltd

Marico Ltd

Nestle India Ltd

JHS Svendgaard Laboratories Ltd About

JHS Svendgaard Laboratories is engaged in manufacturing a range of oral and dental products for elite national and international brands. The main portiolio of the Company is to carry out manufacturing and exporting of oral care and hygiene products including toothbrushes, toothpastes, mouthwash, sanitizers and job work of detergent powder.

Industry

Personal Care - Indian

Founded

2004

Headquarters

CEO

Rajagopal Chakravarthi

Employees

Contact

Website

http://www.svendgaard.com

cs@svendgaard.com; enquiry@svendgaard.com

Phone

91-9218-400346

Location

Trilokpur Road Kheri(Kala Amb), Tehsil Nahan District, Sirmour, Himachal Pradesh, 173030

Year	History
2010	JHS Svendgaard recommended payment of Final Dividend of Rs. 0.50/- per equity share of the face value of Rs. 10/- each
2011	JHS Svendgaard entered an agreement with Amway India Enterprises Private Limited to manufacture Amway Persona Toothbrushes.
2012	JHS Svendgaard entered into an Agreement with Colgate Palmolive (India) Limited to manufacture and supply tooth brushes on job work basis.
2013	JHS won a Certificate Of Excellence.
2014	Mr. Neeraj Kumar was appointed as the CFO of the Company. Ms. Isha Sablok was appointed as Company Secretary of the Company.

Client Name	Order Side	QTY	Avg Price	Date
GREEN PORTFOLIO PRIVATE LIMITED	Sell	537363	11.62	04 Sept 2025
NIMISHA KHANDU SOLANKI	Buy	593100	12	04 Sept 2025
ASPIRE EMERGING FUND	Sell	1500000	28.13	04 Sept 2024
AEGIS INVESTMENT FUND	Buy	1431000	28.13	04 Sept 2024
SIXTH SENSE INDIA OPPORTUNITIES 11	Sell	551400	24.93	23 Aug 2024
SIXTH SENSE INDIA OPPORTUNITIES 11	Sell	500000	24.44	08 Aug 2024
SIXTH SENSE INDIA OPPORTUNITIES 11	Sell	1140000	22.22	07 Aug 2024
MANOJ DUA	Buy	657008	23.03	31 Jul 2024
SIXTH SENSE INDIA OPPORTUNITIES 11	Sell	1019000	23.03	31 Jul 2024
ZAVERI FINSTOCK PVT. LTD.	Sell	468213	22.13	29 Jul 2024

JHS Svendgaard Laboratories Ltd News

JHS Svendgaard Files Q4FY26 SEBI Compliance Certificate

JHS Svendgaard Laboratories submitted mandatory quarterly certificate under SEBI Regulation 74(5) for dematerialization compliance during Q4FY26, covering period from January to March 2026.

15 Apr 2026

companies

JHS Svendgaard Changes Registrar & Transfer Agent

JHS Svendgaard Laboratories announces transition from Alankit Assignments Limited to Beetal Financial and Computer Services as its new Registrar & Share Transfer Agent to strengthen investor services.

15 Apr 2026

companies

JHS Svendgaard Labs Joins IEPF Second Campaign

JHS Svendgaard Laboratories Limited publishes newspaper notice supporting IEPF Authority's second 100 Days Campaign 'Saksham Niveshak' from April 1 to July 9, 2026, aimed at facilitating unpaid dividend claims and KYC updates.

14 Apr 2026

companies

JHS Svendgaard Opens Special Window for Share Transfer

JHS Svendgaard Laboratories Limited announces special window for re-lodgement of physical share transfer requests from February 05, 2026 to February 04, 2027 following SEBI circular.

01 Apr 2026

companies

JHS Svendgaard Files Q3FY26 Fund Utilization Report

JHS Svendgaard Laboratories reported no deviation in utilization of Rs. 29.99 crores raised through preferential issue for Q3FY26, with funds allocated across manufacturing facility equipment and group entity expansion.

10 Feb 2026

stocks

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800